Drug development
Entrada builds medicines that help large biologic drugs get inside cells, then advances its own treatment candidates through research and clinical testing.
Customers
Patients with serious diseases, through doctors and hospitals that would use an approved Entrada medicine.
Revenue Model
If a drug is approved, Entrada would make money from product sales or licensing payments; until then it mainly spends money developing the candidates.